Sort
24,827 grants matching “epilepsy”
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)
$2,902,630Kimford J Meador · Stanford University · U01 · FY2019 · NS
Modulation Of Neuronal Channels and Receptors in the Brain
$2,890,930Jerrel L Yakel · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES
TAM Receptor Signaling in Neurodegenerative Disease
$2,877,690Greg E Lemke · Salk Institute For Biological Studies · RF1 · FY2019 · AG
Modulation Of Neuronal Channels and Receptors in the Brain
$2,877,427Jerrel L Yakel · National Institute Of Environmental Health Sciences · ZIA · FY2015 · ES
3 of 7 Epi4K: Sequencing, Biostatistics & Bioinformatics Core
$2,871,102David B. Goldstein · Duke University · U01 · FY2012 · NS
"Genetic and clinical studies of Gaucher disease and other lysosomal disorders"
$2,870,779Ellen Sidransky · National Human Genome Research Institute · ZIA · FY2009 · HG
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)
$2,860,622Kimford J Meador · Emory University · U01 · FY2013 · NS
Modulation Of Neuronal Channels and Receptors in the Brain
$2,854,957Jerrel L Yakel · National Institute Of Environmental Health Sciences · ZIA · FY2018 · ES
LUM-001 as a Treatment for Creatine Transporter Deficiency
$2,853,144Elizabeth Ottinger · National Center For Advancing Translational Sciences · ZIA · FY2017 · TR
GE Healthcare Discovery MR750 3T MRI System
$2,848,680Frank Korosec · University Of Wisconsin-Madison · S10 · FY2010 · RR
A Phase 3 Pivotal Trial of AGB101 to Slow Progression in MCI due to Alzheimer's Disease
$2,844,834Richard C. Mohs · Agenebio, Inc. · R01 · FY2021 · AG
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)
$2,844,126Kimford J Meador · Emory University · U01 · FY2014 · NS
Roles of TREM2 and TYROBP in AD-related Network Hyperexcitability
$2,833,089Lennart Mucke · J. David Gladstone Institutes · RF1 · FY2023 · AG
Understanding Down Syndrome as an Interferonopathy
$2,830,725Joaquin M. Espinosa · University Of Colorado Denver · R01 · FY2019 · AI
A robust, low-cost platform for EM connectomics
$2,811,375R Clay Reid · Allen Institute · RF1 · FY2021 · MH
Computational and Circuit Mechanisms Underlying Rapid Learning
$2,809,040Elizabeth A Buffalo · University Of Washington · U19 · FY2018 · NS
Involvement Of Human Viruses Associated With Chronic Neurologic Disease
$2,804,788Steven Jacobson · National Institute Of Neurological Disorders And Stroke · ZIA · FY2012 · NS
UC Davis CounterACT Center of Excellence: Developing Therapeutic Strategies for Mitigating the Chronic Neurological Consequences of Acute Organophosphate Intoxication
$2,770,046Pamela J Lein · University Of California At Davis · U54 · FY2024 · NS
UC Davis CounterACT Center of Excellence: Developing Therapeutic Strategies for Mitigating the Chronic Neurological Consequences of Acute Organophosphate Intoxication
$2,762,691Pamela J Lein · University Of California At Davis · U54 · FY2025 · NS
LUM-001 as a Treatment for Creatine Transporter Deficiency
$2,756,223Elizabeth Ottinger · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR
Modulation Of Neuronal Channels and Receptors in the Brain
$2,741,932Jerrel L Yakel · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES
UC Davis CounterACT Center of Excellence: Developing Therapeutic Strategies for Mitigating the Chronic Neurological Consequences of Acute Organophosphate Intoxication
$2,729,988Pamela J Lein · University Of California At Davis · U54 · FY2023 · NS
"Genetic and clinical studies of Gaucher disease and other lysosomal disorders"
$2,713,985Ellen Sidransky · Human Genome Research · Z01 · FY2007 · HG
Mammalian Development and Evolution
$2,713,677Todd Scott Macfarlan · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2025 · HD
UC Davis CounterACT Center of Excellence: Developing Therapeutic Strategies for Mitigating the Chronic Neurological Consequences of Acute Organophosphate Intoxication
$2,713,427Pamela J Lein · University Of California At Davis · U54 · FY2022 · NS